The pharmaceutical sector is riding a wave of vigorous expansion fueled by the escalating demand for medical drugs and vaccines. The industry's steadfast performance can be attributed to the relentless need for its products, making it less vulnerable to economic fluctuations.
Given this backdrop, investors could consider buying fundamentally robust pharma stocks Eton Pharmaceuticals, Inc. (ETON), Ipsen S.A. (IPSEY), and Merck & Co., Inc. (MRK) for consistent gains.
